Rare diseases
Investigational molecules
Locations
Study on Osimertinib and Drug Combination for Adults with Unresectable Non-small Cell Lung Cancer
SpainStudy on Brigatinib for Patients with ALK+ Non-Small Cell Lung Cancer
SpainStudy of adagrasib in elderly patients (70 years or older) or patients with poor performance status who have KRAS G12C mutation-positive non-small cell lung cancer
SpainStudy on Atezolizumab and Trastuzumab Emtansine for Patients with HER2-Positive Breast Cancer at High Risk of Recurrence After Preoperative Therapy
SpainStudy on Olaparib for Patients with High-Risk HER2-Negative Breast Cancer and BRCA1/2 Mutations After Chemotherapy
SpainStudy on the Safety and Immune Response of V116 Vaccine in Children and Adolescents at Higher Risk for Pneumococcal Disease
SpainStudy of Imetelstat Compared to Drug Combination for Treating Intermediate-2 or High-Risk Myelofibrosis in Patients Not Responding to JAK-Inhibitor Treatment
SpainStudy on the Effectiveness and Safety of Fluticasone Propionate and Salbutamol Sulfate for Patients with Asthma
SpainStudy on the Effectiveness and Safety of Litifilimab for Patients with Active Subacute or Chronic Cutaneous Lupus Erythematosus Resistant to Antimalarial Therapy
SpainStudy of Pembrolizumab, Lenvatinib, and Chemotherapy for First-Line Treatment in Extensive-Stage Small Cell Lung Cancer Patients
SpainStudy Comparing Ciltacabtagene Autoleucel with Pomalidomide, Bortezomib, and Dexamethasone for Patients with Relapsed and Lenalidomide-Refractory Multiple Myeloma
SpainStudy on Budigalimab and ABBV-382 for People with HIV on Stable Antiretroviral Therapy
SpainTell us about your condition – we search every trial in Europe and connect you with the right site.
